Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prabhat Kumar et al. JACEP 2016;j.jacep

Published byΕύανδρος Δράκος Modified over 5 years ago

Similar presentations

Presentation on theme: "Prabhat Kumar et al. JACEP 2016;j.jacep"— Presentation transcript:

1 Prabhat Kumar et al. JACEP 2016;j.jacep.2016.06.007
Study Selection Process Study selection process for the inclusion of studies into meta-analysis according to QUOROM (Quality of Reporting of Meta-analyses) guidelines. DFT = defibrillation threshold; HCM = hypertrophic cardiomyopathy; ICD = implantable cardioverter-defibrillator; LVEF = left ventricular ejection fraction; MeSH = Medical Subject Heading. Prabhat Kumar et al. JACEP 2016;j.jacep American College of Cardiology Foundation

Download ppt "Prabhat Kumar et al. JACEP 2016;j.jacep"

Similar presentations

Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.

Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;
American College of Cardiology Presented by Dr. Stuart J. Connolly

American College of Cardiology Presented by Dr. Stuart J. Connolly
Tom F. Brouwer et al. JACEP 2016;2:89-96

Tom F. Brouwer et al. JACEP 2016;2:89-96
José L. Morales et al. JACEP 2017;j.jacep

José L. Morales et al. JACEP 2017;j.jacep
Muhammad Shahreyar et al. JACEP 2016;j.jacep

Muhammad Shahreyar et al. JACEP 2016;j.jacep
Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:
Figure 8 Implanted devices for the management of heart failure

Figure 8 Implanted devices for the management of heart failure
Clyde W. Yancy et al. JACC 2017;70:

Clyde W. Yancy et al. JACC 2017;70:
Noriko Kikuchi et al. JACEP 2016;2:

Noriko Kikuchi et al. JACEP 2016;2:
José L. Morales et al. JACEP 2017;j.jacep

José L. Morales et al. JACEP 2017;j.jacep
Tom F. Brouwer et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:
Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.
Pablo Ávila et al. JACEP 2015;1:

Pablo Ávila et al. JACEP 2015;1:
Shadi Al Halabi et al. JACEP 2015;1:

Shadi Al Halabi et al. JACEP 2015;1:
Tom F. Brouwer et al. JACEP 2016;2:89-96

Tom F. Brouwer et al. JACEP 2016;2:89-96
Alan G. Japp et al. JACC 2016;67:2996-3010 Differentiation of Athlete’s Heart From Early DCM by Myocardial Deformation Imaging Two-dimensional speckle.

Alan G. Japp et al. JACC 2016;67: Differentiation of Athlete’s Heart From Early DCM by Myocardial Deformation Imaging Two-dimensional speckle.
David D. Berg et al. JACC 2018;71:

David D. Berg et al. JACC 2018;71:
Misconceptions and Facts About Hypertrophic Cardiomyopathy

Misconceptions and Facts About Hypertrophic Cardiomyopathy

Similar presentations

Ads by Google